Key result
In anaesthetized rats, intravenous noradrenaline infusion produced a dose-dependent increase in mean arterial blood pressure driven entirely by an increase in cardiac output, with no significant change in total peripheral vascular resistance.
Why the study?
How do adrenoceptor and ganglionic blocking agents modify the cardiovascular response to noradrenaline infusion in anaesthetized rats?
How do adrenoceptor and ganglionic blocking agents modify the cardiovascular response to noradrenaline infusion in anaesthetized rats?
In the anaesthetized rat, noradrenaline raises blood pressure solely by increasing cardiac output rather than peripheral resistance, a balance that is unmasked by adrenoceptor blockade.
Answers are grounded in this paper and cite their sources.
Challenges noradrenaline's assumed vasoconstrictor dominance; leaves open translation to conscious humans or clinical practice.
1 The effects of noradrenaline upon the cardiovascular system of the rat, anaesthetized with pentobarbitone, have been investigated.2 Noradrenaline produces a dose-dependent increase in mean arterial blood pressure (MABP) which is due entirely to an increase in cardiac output; total peripheral vascular resistance (TPR) remains unchanged.3 Following beta-adrenoceptor blockade the pressor response to infused noradrenaline is enhanced and is now due mainly to an increase in TPR; the increment in cardiac output is reduced.4 After alpha-adrenoceptor blockade the pressor response is greatly reduced; the residual increase in MABP is due solely to an increase in cardiac output.5 After ganglion blockade resting cardiac output and TPR both fall, resulting in a reduction in MABP. The pressor response to noradrenaline is enhanced and is now due to increases in both TPR and in cardiac output.6 The cardiovascular response of the anaesthetized rat to noradrenaline can be explained in terms of classical alpha- and beta-adrenoceptor stimulation by the amine; the unusual form of the response may be due to an effective predominance of beta-adrenoceptor-mediated effects in this species.7 It is suggested that the failure of exogenous noradrenaline to produce a rise in TPR results from a balance between the alpha-adrenoceptor-mediated increase and beta-adrenoceptor-mediated decrease in this variable. However, this proposed balance is lost if resting vasoconstrictor tone is reduced by ganglion blockade.
No takes yet. Share an insight, caveat, or question.
Imms et al. (1977) studied Healthy (anaesthetized) (n=30). Noradrenaline infusion vs. Baseline (pre-infusion control) was evaluated on Mean arterial blood pressure (MABP) increase at 1500 ng/min (p=<0.001). In anaesthetized rats, intravenous noradrenaline infusion produced a dose-dependent increase in mean arterial blood pressure driven entirely by an increase in cardiac output, with no significant change in total peripheral vascular resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: